| | | | |  | | By Erin Schumaker, Robert King, Carmen Paun, Ruth Reader and Daniel Payne | | Presented by |  | | | | | | | 
Micky Tripathi at POLITICO's The Future of Patient Care + Access event in Washington on Wednesday | Pixel Me Studio | AI assurance labs are coming, Micky Tripathi, assistant secretary for technology policy and acting chief artificial intelligence officer at HHS, forecasted during POLITICO's The Future of Patient Care + Access event in Washington on Wednesday. The labs would supplement FDA regulation of AI-powered medical devices, vetting AI tools that fall outside the FDA’s regulatory scope. Whether assurance labs should be private, public-private partnerships or government-certified is still an open question, Tripathi said, adding that he is waiting for AI developers and purchasers to reach consensus on what the vetting process should include. He said HHS is closely following a number of private sector-led efforts, including those of the Coalition for Health AI, whose members include Microsoft and the Mayo Clinic; VALID AI, launched at the University of California, Davis; and the Health AI Partnership based at Duke University, but he was careful not to endorse any of them. The department is working on a strategic plan as directed by President Joe Biden in his AI executive order last year, Tripathi said. The HHS team's strategy involves thinking through the roles of private industry and government, and trying to identify how the two can work together to address policy and public interest gaps. Ultimately, the aim is to use federal policy levers to assure the public AI tools work. "A key part of that is the idea of assurance labs," Tripathi told POLITICO's Ruth Reader. HHS Deputy Secretary Andrea Palm said yesterday at the health research group Academy Health’s Datapalooza event in Washington that HHS will release a new AI strategy by January and work on creating an AI safety plan with assurance labs.
| | | | A message from The American Association for Cancer Research®: There have been exciting advances in cancer research and treatment this past year – as shown in the AACR Cancer Progress Report 2024, just released by the American Association for Cancer Research (AACR) today. This report provides the latest statistics on cancer incidence, mortality, and survivorship, and features personal stories from patients who have benefitted from innovative anticancer treatments, highlighting the real-world impact of medical research and the importance of federal funding to advance this progress. See the report. | | | | | | | 
Gunnison, Colo. | Shawn Zeller/POLITICO | | This is where we explore the ideas and innovators shaping health care. The Centers for Medicare and Medicaid Services wants to learn about AI tools that can improve health care outcomes and care delivery. It’s inviting developers to apply to demo their tools for the agency next month. Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Daniel Payne at dpayne@politico.com, Ruth Reader at rreader@politico.com, or Erin Schumaker at eschumaker@politico.com. Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.
| | | | A message from The American Association for Cancer Research®:   | | | | | | | 
Kolaleh Eskandanian of Children's National Hospital and Andrea Downing of The Light Collective at POLITICO's live event today. | Pixel Me Studio | Regulators need to be more transparent about how they’re thinking about rules to govern artificial intelligence in health care, according to a panel held during POLITICO’s The Future of Patient Care + Access event. “Sunlight is the best medicine,” said Andrea Downing, co-founder and president of The Light Collective, an advocacy group that pushes for patients’ rights in health tech. “There is a very clear mistrust in how AI might be leveraged. There are deeply seeded trust issues that are justified in communities who have had trust broken in the past.” Downing pointed to a new community participatory study that showed 91 percent of respondents want to know if AI is being used in their care. Another 74 percent said they think government needs to regulate AI. She called on Congress to update the federal privacy law HIPAA, enacted in 1996 during the “age of the fax machine,” because it doesn't cover much of the health data gathered from patients’ online searches and on smartphone apps. The government also needs to incentivize development of AI tools when the market doesn’t, such as for pediatrics, said Kolaleh Eskandanian, vice president and chief information officer for Children’s National Hospital in Washington. “Children should not be an afterthought,” she said.
| | | | A message from The American Association for Cancer Research®: Today, The American Association for Cancer Research (AACR) released the AACR Cancer Progress Report 2024 revealing how the efforts of researchers working across the cancer science continuum have powered breakthroughs in clinical care that are improving survival and quality of life for patients in the U.S. and around the world. This year’s report includes a spotlight on childhood and adolescent and young adult (AYA) cancers, information about modifiable cancer risk factors such as alcohol use, and features moving survivor stories. Though there has been remarkable progress, cancer remains a significant threat to human health and well-being. In fact, it is estimated that more than 2 million new cases of cancer will be diagnosed in the U.S. in 2024. The tremendous advances outlined in this report have depended on strong federal investments and congressional support is critical to maintain this pace of progress for patients. See the report. | | | | | | | 
| Over the next quarter century, nearly 40 million people could die of infections antibiotics can’t cure, new estimates published Tuesday in The Lancet say. The phenomenon driving those alarming figures, antimicrobial resistance, happens when bacteria no longer respond to treatment. It’s been a major global health problem for years, and it’s going to get worse, said Dr. Christopher Murray, director of the Institute for Health Metrics Evaluation, which led the study with Oxford University in the U.K. The study, which looked at the number of deaths directly caused by or associated with antimicrobial resistance since 1990, is based on estimates from 204 countries and territories. The number of people who died due to antimicrobial resistance increased from just over 1 million a year in 1990 to 1.2 million in 2019. It’s expected to reach nearly 2 million deaths in 2050, a nearly 50 percent increase, if nothing changes. The solutions: The world needs to invest in new antibiotics, ensure that the existing ones are used only when needed — overuse can cause resistance — and remove antibiotics from the food supply, Murray said. | | | | Follow us on Twitter | | | | Follow us | | | | |
No comments:
Post a Comment